AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exelixis Inc
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001SD42W4
64.53▼ 0.78 (-1.19%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
65.31
Day's Range
63.91 – 65.20
52-Week Range
36.00 – 65.50
Volume
2.0M
Avg Volume
2.2M
Share Statistics
Shares Outstanding
Employees
1,077
Exchange
XNAS
Listed
2000-04-11
Share count as of July 27, 2026

Exelixis Inc (EXEL) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Exelixis Inc (EXEL)
What is Exelixis Inc's Market Cap?
Exelixis Inc's Market Cap is $16.0B, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's Enterprise Value?
Exelixis Inc's Enterprise Value is $15.1B, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's Trailing P/E?
Exelixis Inc's Trailing P/E is 18.6×, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's Price / Sales?
Exelixis Inc's Price / Sales is 6.6×, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's EV / Revenue?
Exelixis Inc's EV / Revenue is 6.2×, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's EV / EBITDA?
Exelixis Inc's EV / EBITDA is 15.2×, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's Revenue (TTM)?
Exelixis Inc's Revenue (TTM) is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's Net Income (TTM)?
Exelixis Inc's Net Income (TTM) is $860.6M, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's EBITDA?
Exelixis Inc's EBITDA is $999.8M, based on as-reported figures from SEC (XBRL) filings.
What is Exelixis Inc's Diluted EPS (TTM)?
Exelixis Inc's Diluted EPS (TTM) is 3.47, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · EXELAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJul 3, 2026Apr 3, 2026Jan 2, 2026Oct 3, 2025Jul 4, 2025Apr 4, 2025Jan 3, 2025Sep 27, 2024Jun 28, 2024Mar 29, 2024Dec 29, 2023Sep 29, 2023Jun 30, 2023Mar 31, 2023Dec 30, 2022Sep 30, 2022Jul 1, 2022
Revenues:
Total revenues
YoY growth+10.6%+10.0%+5.6%+10.8%-10.8%
Operating expenses:
Cost of goods sold
Research and development
Selling, general and administrative
Total operating expenses
% of revenue60.5%58.9%60.7%60.4%62.4%
Income from operations
% of revenue39.5%41.1%39.3%39.6%37.6%
Interest income
Other income (expenses), net
Income before income taxes
Provision for income taxes
Segment and consolidated net income
% of revenue33.7%34.5%40.8%32.4%32.5%
Basic (in dollars per share)
Diluted (in dollars per share)